ArticlePharmacoEconomics - open2025

Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.

Leila-Sophie Otten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.